Ginkgo Bioworks Holdings, Inc.

DNA
에너지·유틸리티헬스케어 진단바이오테크·제약
$6.87vs prev close-0.53(-7.16%)
$5.3752W Range$17.58
12% from low
-0.45 (-6.11%)Past 1M
Price
ARK Trade PatternPREMIUM
1M Trades
-
No trades in 1M
1M net buy
$0
0 shares
Portfolio Weight
-
No data
Holding ETFs
1 ETFs
ARKG
Trade Intensity
No trades in 1M
Trade Log
DateActionETFSharesCloseEst. total
24.08.28SELLARKG89$7.08$630
24.08.23SELLARKG1,128$8.15$9.2K
24.08.21SELLARKG10,795$9.31$100.5K
24.08.12SELLARKG994,074$10.48$10.4M
24.08.08SELLARKG2,193,545$11.44$25.1M
24.08.07SELLARKG11,427,110$10.96$125.2M
24.08.06SELLARKG728,880$11.52$8.4M
24.08.05SELLARKG2,081,566$12.16$25.3M
24.07.15SELLARKK100$11.60$1.2K
24.07.12SELLARKK236$11.52$2.7K
24.07.09SELLARKK909$12.36$11.2K
24.07.03SELLARKK28,780$15.04$432.9K
24.07.02SELLARKK985,786$13.88$13.7M
24.07.01SELLARKK886,138$12.92$11.4M
24.06.28SELLARKG · ARKK25,221,264$13.36$337.0M
08.28SELL
89
ARKGClose$7.08Est. total$630
08.23SELL
1,128
ARKGClose$8.15Est. total$9.2K
08.21SELL
10,795
ARKGClose$9.31Est. total$100.5K
08.12SELL
994,074
ARKGClose$10.48Est. total$10.4M
08.08SELL
2,193,545
ARKGClose$11.44Est. total$25.1M
08.07SELL
11,427,110
ARKGClose$10.96Est. total$125.2M
08.06SELL
728,880
ARKGClose$11.52Est. total$8.4M
08.05SELL
2,081,566
ARKGClose$12.16Est. total$25.3M
07.15SELL
100
ARKKClose$11.60Est. total$1.2K
07.12SELL
236
ARKKClose$11.52Est. total$2.7K
07.09SELL
909
ARKKClose$12.36Est. total$11.2K
07.03SELL
28,780
ARKKClose$15.04Est. total$432.9K
07.02SELL
985,786
ARKKClose$13.88Est. total$13.7M
07.01SELL
886,138
ARKKClose$12.92Est. total$11.4M
06.28SELL
25,221,264
ARKG · ARKKClose$13.36Est. total$337.0M
1 / 6

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline
Institutional Holders
1 Holding · 1 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Andreas HalvorsenViking Global Investors
Maintained
Shares
3,577,128
Portfolio Weight
0.08%
Est. Value
$30M
vs Prev Quarter
Maintained
Sold · Q4 2025
Cathie WoodARK Invest
Fully Sold
Portfolio Weight
0%
Prev Holdings
0
Est. Sold Value
$0
Holding Period
-

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Analyst recommendation distribution3
Overall Opinion
Underperform
Hold
1
Sell
1
Strong Sell
1
Analyst Targets
avg.
$7.00
vs Current -5.4% downside
Current$7.40
Low ~ High$5.00 ~ $9.00
Firm
Position
Price Target
Upside / Downside
Close Price
Action
Date
TD Cowen
Hold
$9.00
+21.62%
Downgrade
2026-08-07
BTIG
Sell
$5.00
-32.43%
Maintain
2026-03-12
TD Cowen
Buy
$12.00
+62.16%
Maintain
2026-01-08
BTIG
Sell
$9.00
+21.62%
Maintain
2025-08-25
TD Cowen
Buy
$10.00
+35.14%
Maintain
2024-09-20
1 / 4
Avg Target
$7.00
vs Current -5.4% downside
Underperform
3 analysts
Hold 1Sell 1Strong Sell 1
Low $5.00
Current $7.40
High $9.00
FirmPositionTargetUpsideCloseActionDate
TD CowenHold$9.00+21.62%Downgrade26.08.07
BTIGSell$5.00-32.43%Maintain26.03.12
TD CowenBuy$12.00+62.16%Maintain26.01.08
BTIGSell$9.00+21.62%Maintain25.08.25
TD CowenBuy$10.00+35.14%Maintain24.09.20
1 / 4

Price Information

Previous Close$6.96
Open$7.09
Day Range$6.82 - $7.42
52-Week Range$5.37 - $17.58
1-Year Change-38.59%

Trading Volume

Volume1,325,040
Avg Volume (3mo)1,189,683

Valuation

Market Cap498.3M
Book Value$6.60
Shares Outstanding55,383,808

Financials

Revenue (TTM)132.4M
Net Income-309,639,008
EPS$-5.33
EBITDA-261,624,992

Profitability

P/E Ratio-
P/B Ratio1.12
Return on Equity (ROE)-59.94%
Return on Assets (ROA)-16.72%
Profit Margin-219.61%
EV/EBITDA-2.29
Beta1.79

Dividend

Dividend Rate-
Dividend Yield-

Technical

RSI(14)37.08
Company Overview

Ginkgo Bioworks Holdings, Inc. operates a cell programming platform offering cell engineering R&D solutions and tools like functional genomics and AI models. They also provide biomonitoring and biothreat detection services through their Canopy and Horizon platforms. Ginkgo serves diverse industries including pharmaceuticals, agriculture, and government, positioning itself as a leader in organism engineering.

P/B
1.12
Price-to-Book
ROE
-59.9%
Persistent loss
Beta
1.79
High volatility
RSI(14)
37.1
Neutral zone

AI-generated summary. Not investment advice.

Recent News

Mymoneywood cross-analyzes and curates publicly available SEC 13F-HR filing data. We do not provide investment advice and do not recommend buying or selling any specific securities.

Past performance does not guarantee future results. All investment decisions and responsibilities rest with the user.

Terms of Service·Investment Disclaimer·Privacy Policy·Refund Policy

Always summer | biz@mymoneywood.com
© 2026 Always summer. All rights reserved.

Enter your email below to sign up for the newsletter.

By entering your email you agree to our Privacy Policy. You can unsubscribe anytime.